tau 284 has been researched along with chlorpheniramine in 2 studies
| Studies (tau 284) | Trials (tau 284) | Recent Studies (post-2010) (tau 284) | Studies (chlorpheniramine) | Trials (chlorpheniramine) | Recent Studies (post-2010) (chlorpheniramine) |
|---|---|---|---|---|---|
| 52 | 18 | 21 | 2,040 | 287 | 240 |
| Protein | Taxonomy | tau 284 (IC50) | chlorpheniramine (IC50) |
|---|---|---|---|
| Histamine H1 receptor | Homo sapiens (human) | 0.066 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Kureyama, N; Moriyasu, S; Okamura, K; Yamamoto, K; Yamatodani, A | 1 |
| Fukui, H; Izumi, N; Mizuguchi, H; Ogino, S; Umehara, H | 1 |
2 other study(ies) available for tau 284 and chlorpheniramine
| Article | Year |
|---|---|
Involvement of histamine released from mast cells in acute radiation dermatitis in mice.
Topics: Acute Disease; Animals; Chlorpheniramine; Dose-Response Relationship, Drug; Edema; Erythema; Hair Removal; Histamine; Histamine H1 Antagonists; Histamine Release; Male; Mast Cells; Mice; Mice, Inbred C57BL; Piperidines; Pyridines; Radiodermatitis; Receptors, Histamine H1 | 2007 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniramine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Imidazoles; Japan; Male; Middle Aged; Olopatadine Hydrochloride; Pain Measurement; Piperidines; Population Surveillance; Psychomotor Performance; Pyridines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sleep Stages; Surveys and Questionnaires; Terfenadine; Urticaria | 2008 |